LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

Начало・Списък с акции・West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

Затворен

СекторЗдравеопазване

274.74 -0.61

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

273.32

Максимум

275.11

Ключови измерители
By Trading Economics
Приходи	8.2M 140M
Продажби	38M 804M
P/E Средно за сектора	40.664 78.892
EPS	1.96
Дивидентна доходност	0.31
Марж на печалбата	17.406
Служители	10,600
EBITDA	19M 217M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+27.12% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.31% 2.38%
Следваща дата на дивидент	4.02.2026 г.
Следваща дата на екс-дивидент	28.01.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	9.2M 20B
Предишно отваряне	275.35
Предишно затваряне	274.74

Настроения в новините

By Acuity

34%

66%

87 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

213.26 / 219.27 Подкрепа & съпротива

West Pharmaceutical Services Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.12.2025 г., 21:41 ч. UTC

Придобивния, сливания и поглъщания

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

28.12.2025 г., 23:57 ч. UTC

Печалби

'Avatar: Fire and Ash' Tops Domestic Box Office Again -- Barrons.com

28.12.2025 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

28.12.2025 г., 23:48 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

28.12.2025 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen -- Market Talk

28.12.2025 г., 10:30 ч. UTC

Придобивния, сливания и поглъщания

There's No Happy Ending for Movie Theaters, No Matter Who Wins Warner -- Heard on the Street -- WSJ

26.12.2025 г., 20:22 ч. UTC

Пазарно говорене

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

26.12.2025 г., 20:13 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

26.12.2025 г., 19:24 ч. UTC

Придобивния, сливания и поглъщания

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

26.12.2025 г., 17:45 ч. UTC

Пазарно говорене

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

26.12.2025 г., 15:52 ч. UTC

Пазарно говорене

Oil Futures Turn Lower After Steady Start -- Market Talk

26.12.2025 г., 14:58 ч. UTC

Пазарно говорене

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

26.12.2025 г., 14:41 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

26.12.2025 г., 14:28 ч. UTC

Пазарно говорене

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

26.12.2025 г., 13:47 ч. UTC

Пазарно говорене

Oil Futures Steady in Thin Holiday Trade -- Market Talk

26.12.2025 г., 07:22 ч. UTC

Пазарно говорене

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

26.12.2025 г., 05:03 ч. UTC

Пазарно говорене

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

26.12.2025 г., 03:38 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

26.12.2025 г., 03:38 ч. UTC

Пазарно говорене

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

26.12.2025 г., 02:44 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

26.12.2025 г., 02:44 ч. UTC

Пазарно говорене

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

26.12.2025 г., 01:39 ч. UTC

Пазарно говорене

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

26.12.2025 г., 01:14 ч. UTC

Пазарно говорене

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

26.12.2025 г., 00:34 ч. UTC

Пазарно говорене

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

26.12.2025 г., 00:15 ч. UTC

Пазарно говорене

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

25.12.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25.12.2025 г., 23:40 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25.12.2025 г., 00:20 ч. UTC

Придобивния, сливания и поглъщания

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24.12.2025 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24.12.2025 г., 21:26 ч. UTC

Придобивния, сливания и поглъщания

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

Сравнение с други в отрасъла

Ценова промяна

West Pharmaceutical Services Inc Прогноза

Ценова цел

By TipRanks

27.12% нагоре

12-месечна прогноза

Среден 348.7 USD 27.12%

Висок 375 USD

Нисък 285 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за West Pharmaceutical Services Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на West Pharmaceutical Services Inc през последните 3 месеца.

Техническа оценка

By Trading Central

213.26 / 219.27Подкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bearish.

Настроение

By Acuity

87 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.